APH1A

APH1A is an obligate subunit of the γ-secretase complex that supports the intramembrane proteolysis of substrates including APP and Notch (PMID:15766275, PMID:20130175). Functional reconstitution of PS1, nicastrin, APH-1a, and Pen-2 in insect cells produces an active protease that cleaves the APP-derived C99 substrate and a Notch-like substrate with the expected inhibitor sensitivity and FAD-mutation-driven Aβ42 elevation (PMID:15766275), and APH-1a together with PS1 and Pen2 is sufficient for catalysis even without nicastrin, which serves a stabilizing rather than catalytic role (PMID:20130175). Within the complex APH-1a maintains PS1 levels (PMID:15781968), and structurally it harbors an internal water- and cation-containing hydrophilic cavity (PMID:30979338). APH1A expression and activity are regulated at multiple levels: HIF-1 and YY1 transcriptionally activate the APH-1A promoter to raise APH-1A protein and γ-secretase output (Aβ and NICD) (PMID:16645044, PMID:21443683), GRK-mediated phosphorylation of intracellular loop 2 and the C terminus generates phosphorylation barcodes that recruit β-arrestin 2 to modulate Aβ generation (PMID:35858570), and miR-151-5p directly represses APH1A mRNA (PMID:30663934, PMID:42167224). Through this miRNA-controlled axis, APH1A acts as a γ-secretase/Notch effector: its overexpression elevates NICD to promote neural stem cell proliferation during neocortical development (PMID:42167224) and influences hippocampal memory formation (PMID:30663934). Endogenous APH-1a is notably resistant to degradation by the proteasome and caspases (PMID:16302845, PMID:17596710).

1. 2005 High

   Established that APH-1a is an essential component of an enzymatically active γ-secretase by reconstituting the four-subunit complex and demonstrating substrate cleavage.

   Evidence Baculovirus co-expression of PS1, nicastrin, aph-1a, pen-2 in Sf9 cells with in vitro C99 and N160 cleavage and inhibitor/FAD-mutation assays

   PMID:15766275

   Open questions at the time

   • Did not resolve the individual contribution of APH-1a versus the other subunits to catalysis
   • No structural mechanism of substrate engagement
2. 2005 Medium

   Showed APH-1a supports the stability of the catalytic PS1 subunit, defining a structural/maturation role within the complex.

   Evidence RNAi knockdown of APH-1a in H4 cells expressing wt or FAD Δ9 PS1 with PS1 immunoblot

   PMID:15781968

   Open questions at the time

   • Single lab, single method
   • Mechanism by which APH-1a stabilizes PS1 not defined
3. 2006 Medium

   Identified APH1A as a degradation-resistant protein, ruling out proteasomal turnover as a regulatory mechanism for the endogenous subunit.

   Evidence Proteasome inhibitor treatment across multiple cell types and in vitro 20S proteasome cleavage assay

   PMID:16302845

   Open questions at the time

   • Physiological degradation machinery for APH1A not identified
   • Overexpressed protein behaved differently from endogenous
4. 2006 Medium

   Revealed transcriptional control of APH1A by HIF-1, linking hypoxia to increased γ-secretase activity.

   Evidence Promoter mutagenesis, EMSA, NiCl2 hypoxia, Aβ ELISA and NICD/CTF immunoblot

   PMID:16645044

   Open questions at the time

   • Single lab
   • In vivo relevance of hypoxic induction not tested
5. 2007 Medium

   Confirmed that neither caspases nor the proteasome degrade endogenous APH-1a, reinforcing its unusual stability.

   Evidence In vitro cleavage assays with recombinant caspases and purified/endogenous proteasome

   PMID:17596710

   Open questions at the time

   • Actual turnover pathway remains unknown
   • Corroborates same lab's prior work
6. 2010 High

   Demonstrated that PS1/Pen2/APH-1a is sufficient for γ-secretase catalysis without nicastrin, refining nicastrin's role to complex stabilization.

   Evidence siRNA knockdown panel in NCT-deficient mouse embryonic fibroblasts with endogenous Notch cleavage and inhibitor validation

   PMID:20130175

   Open questions at the time

   • Did not establish whether NCT-independent activity occurs at physiological substrate levels
   • APH-1b/PS2 dispensability shown but not the basis of isoform selectivity
7. 2011 Medium

   Identified YY1 as an allele-specific transcriptional activator of APH1A, connecting a promoter polymorphism to γ-secretase output.

   Evidence EMSA, dual-luciferase reporter, YY1 gain/loss-of-function in N2A and HEK293 cells with Aβ42 measurement

   PMID:21443683

   Open questions at the time

   • Single lab
   • In vivo and disease-association significance of the -980G allele not established
8. 2019 Low

   Proposed a structural cavity in APH-1A capable of storing water and admitting cations, hinting at a role beyond scaffolding.

   Evidence Molecular dynamics and umbrella sampling simulations on the cryo-EM γ-secretase structure

   PMID:30979338

   Open questions at the time

   • Computational only, no experimental validation of ion/water handling
   • Functional consequence for catalysis untested
9. 2019 Medium

   Established miR-151-5p as a direct post-transcriptional repressor of APH1a with consequences for memory formation.

   Evidence Luciferase reporter validation of 3'UTR targeting plus in vivo miR-151-5p inhibition with fear conditioning

   PMID:30663934

   Open questions at the time

   • Single lab
   • Whether γ-secretase/Notch activity mediates the memory phenotype not directly tested here
10. 2022 Medium

    Defined GRK phosphorylation of APH1A ICL2 and C terminus as a regulatory barcode that recruits β-arrestin 2 to tune Aβ generation, importing GPCR-like regulation into γ-secretase control.

    Evidence Phosphorylation assays, APH1A–βarr2 Co-IP, Aβ measurement, site mutagenesis and molecular dynamics

    PMID:35858570

    Open questions at the time

    • Specific GRK isoforms responsible not fully resolved
    • Reciprocal validation and in vivo relevance limited
11. 2026 Medium

    Placed APH1A as a direct downstream effector of the miR-151-5p axis in neural stem cell fate, acting through NICD elevation to promote proliferation.

    Evidence Conditional miR-151-5p knockout mouse, APH1A overexpression rescue, NICD immunoblot and SOX2/NSC proliferation assays

    PMID:42167224

    Open questions at the time

    • Does not separate APH1A's Notch effect from broader γ-secretase substrate processing
    • Single study

• The physiological turnover pathway for endogenous APH1A and the in vivo significance of its GRK/β-arrestin and structural cavity regulation remain unresolved.
• Endogenous degradation route unknown
• Cavity ion/water role unvalidated
• GRK isoform specificity and physiological context incomplete